Description
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
Product Unit Size | Cost | Quantity | Stock |
---|
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
Cas No. | 1022958-60-6 |
---|---|
Purity | ≥98% |
Formula | C28H35ClN6O3 |
Formula Wt. | 539.08 |
IUPAC Name | (1S,2S,3R,4R)-3-[(5-Chloro-2-{[(7S)-1-methoxy-7-(4-morpholinyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]amino}-4-pyrimidinyl)amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide |
Synonym | CEP 28122, CEP28122 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Cheng M., Quail M., et al. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Mol Cancer Ther. 11(3):670-79 (2012). PMID: 22203728.
FIASMA, μOR agonist, potential HCN channel blo...
Hexokinase inhibitor, aerobic glycolysis inhibi...
Synthetic cyclic dinucleotide agonist of STING....
Peptide, derivative of AT I, cleavage product o...
Flavone found in Teucrium.
Peptide, carbonic anhydrase G250 epitope.
Bisphosphonate; squalene synthase inhibitor.
Aurora kinase A inhibitor.
Loop diuretic; NKCC symporter and KCC2 co-trans...
Mycotoxin produced by Aspergillus; actin polyme...
Thienylbutyl ITC analog.
SERCA inhibitor.
Endogenous peptide fragment, involved in vasoco...
CDK9 inhibitor.
p110β PI3K inhibitor.
Alkaloid produced by Streptomyces, DNA cross-li...
Peptide, involved in feeding behavior and insul...
Dihydropyridine; L-type Ca2+ channel blocker.
Pyrimidine nucleoside base, pairs with adenosin...
BHA derivative, antioxidative food and cosmetic...